Zhipeng Li

685 total citations
38 papers, 534 citations indexed

About

Zhipeng Li is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Zhipeng Li has authored 38 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Biomaterials, 11 papers in Biomedical Engineering and 10 papers in Molecular Biology. Recurrent topics in Zhipeng Li's work include Nanoplatforms for cancer theranostics (9 papers), Nanoparticle-Based Drug Delivery (7 papers) and Retinal Diseases and Treatments (3 papers). Zhipeng Li is often cited by papers focused on Nanoplatforms for cancer theranostics (9 papers), Nanoparticle-Based Drug Delivery (7 papers) and Retinal Diseases and Treatments (3 papers). Zhipeng Li collaborates with scholars based in China and United States. Zhipeng Li's co-authors include Jingliang Wu, Bo Zhang, Yong Sun, Guixiang Tian, Hong Jiang, Ruiyan Pan, Jianqin Yan, Ning Fang, Hongli Yu and Di Wang and has published in prestigious journals such as Biomaterials, Bioresource Technology and Journal of Agricultural and Food Chemistry.

In The Last Decade

Zhipeng Li

35 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhipeng Li China 14 190 145 144 47 43 38 534
Farshad Mirzavi Iran 14 212 1.1× 112 0.8× 142 1.0× 52 1.1× 33 0.8× 48 561
Haiyan Hu China 13 252 1.3× 99 0.7× 92 0.6× 49 1.0× 23 0.5× 21 505
Sara Nikoofal‐Sahlabadi Iran 12 177 0.9× 147 1.0× 125 0.9× 30 0.6× 56 1.3× 16 475
Pavan Kumar Chintamaneni India 14 255 1.3× 187 1.3× 138 1.0× 51 1.1× 33 0.8× 26 675
Lianzhi Mao China 13 231 1.2× 110 0.8× 86 0.6× 72 1.5× 66 1.5× 22 559
Banafshe Abadi Iran 11 169 0.9× 142 1.0× 110 0.8× 48 1.0× 121 2.8× 15 548
Lama Hamadneh Jordan 12 173 0.9× 98 0.7× 97 0.7× 55 1.2× 33 0.8× 50 516

Countries citing papers authored by Zhipeng Li

Since Specialization
Citations

This map shows the geographic impact of Zhipeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhipeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhipeng Li more than expected).

Fields of papers citing papers by Zhipeng Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhipeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhipeng Li. The network helps show where Zhipeng Li may publish in the future.

Co-authorship network of co-authors of Zhipeng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zhipeng Li. A scholar is included among the top collaborators of Zhipeng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhipeng Li. Zhipeng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Xiao, Miaomiao Zhao, Shujie Sun, et al.. (2025). Co-loaded aspirin and doxorubicin by chondroitin sulphate nanoparticles inhibited metastasis of breast cancer by squelching circulating tumor microemboli. Colloids and Surfaces B Biointerfaces. 255. 114942–114942.
2.
Li, Zhipeng, et al.. (2025). Neuroimmunology-driven CAR T-cell therapeutics for gliomas: translational challenges and clinical trial paradigm innovation. Cancer Letters. 631. 217928–217928. 1 indexed citations
3.
Wu, Jingliang, Rui Li, Shujie Sun, et al.. (2025). pH-sensitive hyaluronic acid nanomicelles for co-delivery of capsaicin and doxorubicin enhance the treatment of anaplastic thyroid carcinoma. Colloids and Surfaces B Biointerfaces. 254. 114827–114827. 1 indexed citations
4.
Zheng, Mingjing, Zhipeng Li, Tao Hong, et al.. (2024). Ultra-high pressure assisted extraction of polysaccharide from Bangia fusco-purpurea: Structure and in vitro hypolipidemic activity. International Journal of Biological Macromolecules. 280(Pt 4). 135687–135687. 13 indexed citations
5.
Wu, Yanyan, Tao Hong, Yuanfan Yang, et al.. (2024). Antifungal mechanism and application to phytopathogenic fungi after anaerobic fermentation of Gracilaria agar wastewater. Bioresource Technology. 416. 131818–131818. 2 indexed citations
6.
Li, Zhipeng, et al.. (2023). Efficiency co-delivery of ellagic acid and oxygen by a non-invasive liposome for ameliorating diabetic retinopathy. International Journal of Pharmaceutics. 641. 122987–122987. 14 indexed citations
7.
Yan, Jianqin, et al.. (2023). Recent trends in emerging strategies for ferroptosis-based cancer therapy. Nanoscale Advances. 5(5). 1271–1290. 18 indexed citations
8.
Tian, Ke, Ying Deng, Zhipeng Li, Huaxin Zhou, & Hui Yao. (2023). AKR1B10 inhibits the proliferation and metastasis of hepatocellular carcinoma cells by regulating the PI3K/AKT pathway. Oncology Letters. 27(1). 18–18. 7 indexed citations
9.
Hu, Yang, Lijun Li, Zedong Jiang, et al.. (2023). Effect of ultra-high pressure treatment on structural and functional properties of dietary fiber from pomelo fruitlets. Food Bioscience. 52. 102436–102436. 41 indexed citations
10.
Xie, Mingjie, et al.. (2023). Characteristics of endoplasmic reticulum stress in colorectal cancer for predicting prognosis and developing treatment options. Cancer Medicine. 12(10). 12000–12017. 11 indexed citations
11.
Yan, Jianqin, Yan Liang, Hongli Yu, et al.. (2022). Nanodrug delivery systems and cancer stem cells: From delivery carriers to treatment. Colloids and Surfaces B Biointerfaces. 217. 112701–112701. 14 indexed citations
12.
Li, Zhipeng, et al.. (2022). Combination of polythyleneimine regulating autophagy prodrug and Mdr1 siRNA for tumor multidrug resistance. Journal of Nanobiotechnology. 20(1). 476–476. 26 indexed citations
13.
Teng, Yi, et al.. (2022). Combined Ibuprofen-Nanoconjugate Micelles with E-Selectin for Effective Sunitinib Anticancer Therapy. International Journal of Nanomedicine. Volume 17. 6031–6046. 10 indexed citations
14.
Li, Zhipeng, Yanying Li, Xiaoxue Wang, et al.. (2021). Combined anti-hepatocellular carcinoma therapy inhibit drug-resistance and metastasis via targeting “substance P-hepatic stellate cells-hepatocellular carcinoma” axis. Biomaterials. 276. 121003–121003. 48 indexed citations
15.
Li, Zhipeng, et al.. (2021). Normalization of the tumor microvasculature based on targeting and modulation of the tumor microenvironment. Nanoscale. 13(41). 17254–17271. 29 indexed citations
16.
Li, Zhipeng, Guixiang Tian, Hong Jiang, et al.. (2019). <p>Liver-Targeting and pH-Sensitive Sulfated Hyaluronic Acid Mixed Micelles for Hepatoma Therapy</p>. International Journal of Nanomedicine. Volume 14. 9437–9452. 29 indexed citations
17.
Jiang, Hong, Zhipeng Li, Guixiang Tian, et al.. (2019). <p>Liver-targeted liposomes for codelivery of curcumin and combretastatin A4 phosphate: preparation, characterization, and antitumor effects</p>. International Journal of Nanomedicine. Volume 14. 1789–1804. 45 indexed citations
18.
Wu, Yadong, Zhipeng Li, Hui Lv, et al.. (2018). Fabrication, characterization and biocompatibility of collagen/oxidized regenerated cellulose-Ca composite scaffold for carrying Schwann cells. International Journal of Biological Macromolecules. 119. 1195–1203. 5 indexed citations
19.
Li, Zhipeng, Rong Yang, Ruirong Yuan, et al.. (2010). Molecular diagnosis and targeted therapy of a pediatric chronic eosinophilic leukemia patient carrying TPM3‐PDGFRB Fusion. Pediatric Blood & Cancer. 56(3). 463–466. 12 indexed citations
20.
Wang, JinRong, et al.. (2008). [Mechanism of conditioned immune response in curing bronchial asthma in mice].. PubMed. 46(12). 924–9.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Farshad Mirzavi Breakdown of academic impact, for papers by Haiyan Hu Breakdown of academic impact, for papers by Sara Nikoofal‐Sahlabadi Breakdown of academic impact, for papers by Pavan Kumar Chintamaneni Breakdown of academic impact, for papers by Lianzhi Mao Breakdown of academic impact, for papers by Banafshe Abadi Breakdown of academic impact, for papers by Lama Hamadneh
Rankless by CCL
2026